Latest Development Pipeline News

Ingenia Communities Group confirms it is in discussions with Peet Limited and potential capital partners to explore extending its land bank and accelerating growth in the land lease segment.

Mesoblast Limited’s Ryoncil® posted US$36 million in Q4 revenue, driving a full-year total of US$115 million, exceeding initial forecasts. The FDA-approved stem cell therapy for pediatric graft-versus-host disease shows robust uptake across US pediatric centres.

Alkane Resources delivered 42,491 ounces gold equivalent in the June quarter, pushing full-year production to 168,337 ounces and bolstering cash and investments to $454 million.

Midas Minerals has unveiled new high-grade copper and silver drill results at its T-13 Deposit within the Otavi Copper Project, revealing an expanded footprint of premium mineralisation and a promising upgrade to its resource base.

Summerset Group maintained stable new sales in Q2 2026 with a notable 26% jump in resales, while prudently reducing its New Zealand build rate in response to economic uncertainty.

Dexus's latest external valuations reveal a modest 0.2% decline in its stabilised office and industrial portfolio values as of June 2026, reflecting subtle shifts in capitalisation rates and rental growth.

Catalyst Metals has delivered a record 31,812 ounces of gold in the latest quarter and 104,000 ounces for FY26 from the Plutonic Gold Belt, doubling quarterly production since acquisition and maintaining a strong cash position.

Echo IQ has locked in a pivotal exclusive data licensing deal with Advara HeartCare, gaining access to as many as one million de-identified echocardiography studies, a move set to turbocharge its cardiovascular AI development.

Lendlease has partnered with The Crown Estate to form the Impact Partnership Joint Venture, unlocking a £24 billion UK development pipeline including up to 30,000 new homes and nearly a million square metres of office and life sciences space.

CDL Investments New Zealand (NZX: CDI) has secured Fast-track referral approval for its Middle Road residential development in Havelock North, paving the way for up to 350 new homes and reinforcing its Hawke’s Bay growth pipeline.

Recce Pharmaceuticals secured A$4 million through an institutional placement and launched a Share Purchase Plan to raise up to an additional A$4 million, bolstering funds for commercial licensing and ongoing clinical programs.

HMC Capital has cleared key regulatory hurdles and locked in a $603 million investment from KKR, trimming its stake in the energy platform now rebranded as Illuma Energy. The deal paves the way for expanded battery storage projects and underpins a targeted development milestone in 2026.